A 12 month subscription to our “Gastric Cancer – Continuous Forecasting and Advisory Service” provides clients with a comprehensive study of the gastric cancer market with forecasting until 2020. At the heart of the Continuous Forecasting and Advisory Service” is a 350+ page report that analyses the gastric cancer therapeutics market in the US, the UK, France, Germany, Spain, Italy and Japan and the emerging countries of Brazil, Russia, India, and China with detailed market forecasts up to 2020. As a subscriber to the service you will also receive supporting drug sales and patient volume models in excel format, a PowerPoint presentation pack, a 2 hour personalized interactive webinar with GlobalData’s Oncology Analysis Team, Access to GlobalData’s Continuous Forecasting and Advisory Service, Quarterly updates of the gastric cancer report, PPT presentation pack and drug sales and patient volume models. You will also have access to our analysts; on hand to support you and answer any questions you may have.
350+ page report providing an in-depth analysis of the gastric cancer market
Data forecasts until 2020 covering 11 countries worldwide
Geographical coverage – analysis of the US, UK, Germany, France, Italy, Spain and Japan, as well as emerging countries such as Brazil, Russia, India and China
Drug sales for gastric cancer until 2020, including forecasted drug sales for pipeline products
Treatment usage pattern including treatment seeking, diagnosis and prescription population
Strategic assessment of the pipeline and current products backed by detailed data
Assessment of recent events and their effects on the market landscape
Direct quotes from 70 key opinion leader (KOL) physicians per report across 11 countries
Supporting drug sales and patient volume models in excel format
PowerPoint presentation pack
2 hour personalized interactive webinar with GlobalData’s Oncology Analysis Team
Access to GlobalData’s Continuous Forecasting and Advisory Service
Quarterly updates of the gastric cancer report, PPT presentation pack and drug sales and patient volume models
Analysts on hand to support you and answer any questions you may have
Reasons to Buy
Track and forecast drug sales by country from 2002 to 2020
Quantify and assess unmet needs in the gastric cancermarket
Monitor the deals and licensing landscape
Understand pricing and reimbursement methodologies across countries
Perform market sizing, forecasts and quantified growth opportunities in the market till 2020
Understand diseases opportunities in emerging countries such as Brazil, Russia, India and China
Quantify patient population in all countries to better design product pricing & launch plans
Perform benchmarking analysis and growth opportunities against currently marketed products
Identify market entry points based on safety, efficacy, and pricing parameters
Assess competitiveness of products in the market by understanding the strength and weakness of the current competition
Assess strength of pipeline bases on first in class, me-too, generic and lifecycle management of products
Perform clinical trials and pipeline analysis to keep up to date with latest environmental changes
Table of Contents
List of Tables
List of Figures
Tel +44 (0) 20 7947 2960
Every customer’s requirement is unique. We understand that and can customize the report basis your exact research requirements pertaining to market insights, innovation insights, strategy and planning, and competitive intelligence. You can also avail the option of purchasing stand-alone sections of the report or request for a country specific report.
“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.
GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”
“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”
Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.
Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.